WHO ICTRP trial

A Randomized Controlled Study on the Efficacy and Safety of Chinese Medicine…

ITMCTR2100004703 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting

Key facts

Trial ID ITMCTR2100004703
Public title A Randomized Controlled Study on the Efficacy and Safety of Chinese Medicine Xinju Nebulized Liquid in the Treatment of Allergic Rhinitis
Scientific title Research on advantage breakthrough of the theory of ''preventive treatment of disease'' in the prevention and treatment of allergic rhinitis
Primary sponsor Guangdong Provincial Hospital of Chinese Medicine
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions allergic rhinitis
Interventions Control Group:Physiological saline spray inhalation;treatment group:Xinju spray inhalation
Registration date Apr 7, 2021
Target size Control Group:52;treatment group:52
Secondary IDs ChiCTR2100045156;ChiMCTR2100004703
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations